Search

everythinglearnresearchcommunity

for

Search:↓

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Graft-versus-host disease occurs when donor immune cells attack the recipient's body, causing skin, gut, and liver damage.

Human pluripotent stem cells could be used to make platelets for medical use, but safety, effectiveness, and cost issues need to be resolved.

New regenerative therapies show promise for treating hair loss.

Human mesenchymal stem cells show promise for treating skin diseases, but more research is needed to improve treatments.

cGVHD often severely affects the skin, causing rapid aging and other issues.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Stem cell therapy improves healing and reduces pain in cutaneous radiation syndrome.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.

New techniques and materials improve sternum reconstruction and patient quality of life.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Platelet concentrates are useful for tissue repair in medicine and dentistry, with L-PRF showing promising results in various treatments.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Hematopoietic stem cell transplantation does not significantly affect COVID-19 severity in children with immune disorders.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

The study found that the quality of cord blood units remains consistent before freezing and after thawing, indicating that attached tube segments reliably represent the graft's properties.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Rehabilitation improved patients' mobility but did not reduce 30-day hospital readmission rates after stem cell transplants.

Understanding cellular interactions in VCA may lead to better treatments and reduce rejection.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Entospletinib effectively prevents eye and skin GVHD in mice.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.